Biotechnology Companies By Current Ratio

Current Ratio
Current RatioEfficiencyMarket RiskExp Return
1SBFM Sunshine Biopharma
401.11
(0.20)
 9.57 
(1.87)
2SSIC Silver Spike Investment
111.63
 0.05 
 2.56 
 0.12 
3GHRS GH Research PLC
86.02
 0.16 
 4.14 
 0.67 
4SBFMW Sunshine Biopharma Warrant
85.09
 0.17 
 207.88 
 34.40 
5PMCB PharmaCyte Biotech
75.51
(0.03)
 2.86 
(0.08)
6GLSI Greenwich LifesciencesInc
65.74
 0.04 
 5.08 
 0.19 
7RZLT Rezolute
61.78
 0.25 
 5.27 
 1.31 
8CELZ Creative Medical Technology
58.88
(0.06)
 2.05 
(0.13)
9XENE Xenon Pharmaceuticals
57.86
 0.18 
 2.23 
 0.40 
10KTTA Pasithea Therapeutics Corp
51.17
 0.09 
 10.01 
 0.86 
11TYRA Tyra Biosciences
50.83
 0.16 
 5.48 
 0.89 
12NAUT Nautilus Biotechnology
49.75
(0.02)
 3.82 
(0.07)
13DSGN Design Therapeutics
48.96
 0.08 
 3.04 
 0.25 
14SNPX Synaptogenix
47.22
 0.01 
 8.85 
 0.12 
15BCTX Briacell Therapeutics Corp
45.0
(0.12)
 5.05 
(0.59)
16EPIX ESSA Pharma
43.43
 0.18 
 6.55 
 1.17 
17DRTS Alpha Tau Medical
41.98
 0.00 
 3.21 
 0.00 
18AVTE Aerovate Therapeutics
40.85
 0.13 
 5.39 
 0.68 
19LEXX Lexaria Bioscience Corp
40.09
 0.22 
 7.43 
 1.62 
20KZR Kezar Life Sciences
39.64
 0.11 
 3.67 
 0.40 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company. Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).